Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation

Europace

Volumn 8, Issue 2, 2006, Pages 107-112

  Hemels, Martin E W ^a   Wiesfeld, Ans C P ^a   Inberg, Bas ^a   Van Dessel, Pascal F H M ^a   Nieuwland, Wiebe ^a   Tan, Eng S ^a   Mulder, Henk ^a   Van Veldhuisen, Dirk J ^a   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Pacing

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; SOTALOL;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOREIGN BODY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RIGHT ATRIUM; HEMATOMA; HUMAN; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PROPHYLAXIS;

AGED; ALGORITHMS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 33745271364     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euj004     Document Type: Article

References (29)

1. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833.
2. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
3. Van Gelder IC, Crijns HJ, Tieleman RG et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996;156:2585-2592.
4. Haïssaguerre M, Shah DC, Jaïs P et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102: 2463-2465.
5. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-197.
6. Cox JL, Schuessler RB, Boineau JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:2-14.
7. Cooper JM, Katcher MS, Orlov MV. Implantable devices for the treatment of atrial fibrillation. N Engl J Med 2002;346:2062-2068.
8. Israel CW, Hugl B, Unterberg C et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.
9. Tse HF, Lau CP, Ayers GM. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion. Eur Heart J 2000;21:1167-1176.
10. Friedman PA, Dijkman B, Warman EN et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104: 1023-1028.
11. Gillis AM, Wyse DG, Connolly SJ et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553-2558.
12. Wiberg S, Lonnerholm S, Jensen SM et al. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: A multicenter randomized study, the PAF-PACE study. Pacing Clin Electrophysiol 2003;26:1841-1848.
13. Camm J, for the AF Therapy Investigators. AF Therapy study: Prevention pacing for paroxysmal atrial fibrillation. (Abstract). Pacing Clin Electrophysiol 2002;24:554.
14. Lau CP, Tse HF, Yu CM et al. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol 2001;88:371-375.
15. Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998;32:1900-1908.
16. Garrigue S, Barold SS, Cazeau S et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 1998;21:1751-1759.
17. Padeletti L, Purerfellner H, Adler SW et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14: 1189-1195.
18. Carlson MD, Ip J, Messenger J et al. A new pacemaker algorithm for the treatment of atrial fibrillation - Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-633.
19. Lee MA, Weachter R, Pollak S et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.
20. Saksena S, Prakash A, Ziegler P et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;40:1140-1150.
21. Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: Results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001;12:912-917.
22. Madan N, Saksena S. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am J Cardiol 2004;93:569-575.
23. Padeletti L, Pieragnoli P, Ciapetti C et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1047-1055.
24. Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N. Atrial septal pacing: A new approach to prevent atrial fibrillation. Pacing Clin Electrophysiol 2004;27:850-854.
25. Manegold JC, Hohnloser SH, Israel CW, Goethe JW. Pacing as hybrid therapy of atrial fibrillation: Results of a 5 year observational study. (Abstract). Circulation 2004;110:III-344.
26. Madrid AH, Buena MG, Rebollo JM et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study. Circulation 2002;106:331-336.
27. Ueng KC, Tsai TP, Yu WC et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003;24:2090-2098.
28. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
29. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246.